| Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725) |
|---|
| 08/30/2006 | EP1694627A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors |
| 08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/17/2006 | US20060183870 Triamantane diamondoid nucleus |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/16/2006 | CN1269812C Slfonium salts, methods for their preparation and use thereof as photoinitiators for radiation curable systems |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/10/2006 | WO2006082010A1 Inhibitors of diacylglycerol acyltransferase (dgat) |
| 08/10/2006 | CA2596639A1 Inhibitors of diacylglycerol acyltransferase (dgat) |
| 08/09/2006 | EP1686983A1 Use of pentadienoic acid derivates for treatement of hyperuricemia |
| 08/09/2006 | CN1268623C Novel composition and method or stabilizing same |
| 08/08/2006 | US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/08/2006 | US7087416 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET) |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2006032893A3 Trityl derivatives for enhancing mass spectrometry |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1140811B1 Novel herbicides |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | EP0970935B1 Method of separating optical isomers |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/27/2006 | WO2006026033A3 Novel chalcogenoxanthylium dyes for purging blood pathogens and for photodynamic therapy |
| 07/27/2006 | US20060167055 Non-nucleoside reverse transcriptase inhibitors |
| 07/27/2006 | US20060166944 tetracycline derivatives such as 4-Oximinominocycline, used for the treatment of bacterial infections, as antitumor agents, blocking tetracycline efflux and modulation of gene expression |
| 07/26/2006 | CN1809530A Haloalkyl containing compounds as cysteine protease inhibitors |
| 07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |
| 07/19/2006 | CN1264839C Non-nucleoside reverse transcriptase inhibitors |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/11/2006 | US7074819 Benzopyran or thiobenzopyran derivatives |
| 07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/05/2006 | CN1796370A Compound substitution heterocycle class |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/29/2006 | US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/28/2006 | EP1673365A1 Process for the preparation of z-flupentixol |
| 06/28/2006 | CN1795190A Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | CA2589363A1 Spiro derivatives as lipoxygenase inhibitors |
| 06/21/2006 | EP1670739A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 06/15/2006 | US20060128790 5,7,8-Trimethyl-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-6-ol; also analogous thiochromenes; antiapoptosis; anticarcinogenic agents; antihypoxic agents; anoxia; antiinflamatory agents; central nervous system disorders; autoimmune diseases; neurodegenerative disorders |
| 06/15/2006 | US20060128786 Compounds for the treatment of alzheimer's disease |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/08/2006 | WO2006059345A2 Process for the preparation of acetylenic retinoid |
| 06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 06/08/2006 | CA2558647A1 Insecticidal n-substituted sulfoximines |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 05/31/2006 | EP1661885A1 Optically active alpha-aminooxyketone derivatives and process for production thereof |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/23/2006 | US7049374 Heterodiamondoids |
| 05/18/2006 | WO2006051137A1 Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran |
| 05/18/2006 | US20060106233 Process for the preparation of disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/16/2006 | US7045514 Therapeutic heterocyclic compounds |
| 05/16/2006 | CA2291650C Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653945A2 Glycosidase inhibitors and methods of synthesizing same |
| 05/03/2006 | EP1652843A1 Amide derivatives |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 04/25/2006 | US7033727 Photosensitive composition and acid generator |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/19/2006 | CN1252042C Oximate light initiator |
| 04/18/2006 | US7030250 Process for obtaining 4-(N-alkylamino)-5,6-dihydro-4H-thien-(2,3-b)-thiopyran-2-sulfonamide-7,7-dioxides and intermediates |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/12/2006 | EP1645271A1 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 03/30/2006 | WO2006034004A2 Processes and intermediates for preparing cysteine protease inhibitors |
| 03/30/2006 | WO2006032893A2 Trityl derivatives for enhancing mass spectrometry |
| 03/30/2006 | CA2580065A1 Processes and intermediates for preparing cysteine protease inhibitors |
| 03/29/2006 | CN1247581C Processes for the preparation of carbapenem-type antibacterial agents |
| 03/22/2006 | EP1636160A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP0962456B1 Cyclic ketone derivative and pharmaceutical use thereof |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/16/2006 | US20060058264 (2S,4aS,6aR,7R,9S,10aS,10bR)-9-(hydroxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester, for treating pain, drug or alcohol addiction; side effect reduction |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | CA2268796C Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 03/02/2006 | CA2577389A1 Psorospermin and analogues |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/15/2006 | CN1241907C Organic compounds |
| 02/14/2006 | US6998493 Colorant compounds |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/02/2006 | WO2006011669A1 Novel cinnamic acid related compounds |
| 02/02/2006 | WO2006011047A1 Enantioselective method for separing substituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 02/02/2006 | US20060025471 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
| 02/02/2006 | CA2574363A1 Enantioselective method for separating sustituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| 02/02/2006 | CA2571587A1 Quaternary salt ccr2 antagonists |
| 02/01/2006 | CN1729183A Novel lapachone compounds and methods of use thereof |
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/31/2006 | US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders |